Introduction

Hereditary hearing impairment is genetically heterogeneous, exhibiting patterns of inheritance that include: autosomal recessive, autosomal dominant, X-linked and mitochondrial. Nonsyndromic deafness represents 70% of all cases. Nonsyndromic autosomal recessive deafness accounts for up to 80% of nonsyndromic hereditary hearing loss. To date, 52 loci responsible for this form of deafness have been mapped and 24 genes identified.1, 2, 3, 4 Among all DFNB loci, the most prevalent one is DFNB1 (GJB2 and GJB6 genes,5, 6 MIM 121011 and 604418) that accounts for up to 50% of recessive cases. Other loci with a significant number of different families associated are DFNB4 (SLC26A4 gene,7 MIM 605646), DFNB9 (OTOF gene,8 MIM 603681), DFNB12 (CDH23 gene,9 MIM 605516), DFNB7/11 (TMC1 gene,10 MIM 606706), followed by DFNB8/10 (TMPRSS3 gene,11 MIM 605511) and DFNB3 (MYO15A gene,12 MIM 602666).

Here, we report the study of a large inbred Brazilian pedigree with 26 individuals affected by prelingual deafness and presumed autosomal recessive inheritance to map the responsible gene. Instead of an expected homozygous mutation, we found two different novel MYO15A mutations segregating and evidence for other genetic and/or environmental causes for deafness in the same pedigree. Our findings illustrate the high level of genetic heterogeneity in deafness and the pitfalls of genetic linkage analysis in large pedigrees.

Patients and methods

Subjects

The proband was referred to our genetic counseling service (Centro de Estudos do Genoma Humano, State of São Paulo, Brazil) by the clinical and educational institution DERDIC (Divisão de Educação e Reabilitação de Distúrbios da Comunicação, Pontifícia Universidade Católica de São Paulo). The parents of the proband were referred as nonconsanguineous, but his mother belonged to a large multigenerational inbred family living in a remote small village located in the countryside of a small town in the Northeast of Brazil. According to the local health care authorities, the small village had about 815 people, of whom 33 were affected by hearing impairment. The ascertained pedigree included 26 individuals affected by prelingual hearing loss (Figure 1).

Figure 1
figure 1

Pedigree showing the haplotypes of the DFNB3 chromosomal region. The black and the gray haplotypes segregate with deafness. Subjects from branch 1 are compound heterozygous for mutations c.10573delA/c.9957_9960delTGAC in the MYO15A gene; subjects from branch 2 are homozygous for c.10573delA mutation, the exception is subject VII:2 (*) who is a compound heterozygote, like subjects from branch 1. Subjects from branches 3 and 4 did not present any of these mutations.

Audiological evaluation

After performing otoscopy, rinoscopy and oroscopy exams, pure tone audiometry was carried out to test for air conduction (250–8000 Hz) and bone conduction (250–4000 Hz). Pure tone audiometry was not performed in three of the 26 deaf subjects due to mental impairment (VI:4, VI:17 and VI:19).

Ethical approval of study

This study was approved by CONEP, the Brazilian National Committee on Ethics in Research. After appropriate written informed consents were obtained, blood samples were collected from 59 family members (26 affected).

Molecular genetic analysis

DNA was extracted by standard techniques using Kits such as ‘Easy-DNA™ Kit (Version D) Genomic DNA Isolation’ from Invitrogen (Carlsbad, CA, USA), a GFX Genomic Blood DNA Purification Kit (Amersham Biosciences, Buckinghamshire, UK) or using an equipment Autopure LS (Gentra Systems, Minneapolis, MN, USA).

Screening for common deafness mutations

The c.35delG mutation (GJB2 gene) was detected by allele-specific PCR as described by Scott et al.13 Sequencing of the coding exon of the GJB2 gene was performed in patients V:7, VI:17, VI:19, VI:3, VI:4 and VIII:1. Two fragments were amplified to sequence the entire coding exon. The first fragment was amplified with primers 1F – 5′-GTGTTGTGTGCATTCGTCTTTTC-3′ and 3R – 5′-ACCTTCTGGGTTTTGATCTCCTC-3′, and the second with primers 4F – 5′-GGAAGTTCATCAAGGGGGAGATA-3′ and 2R – 5′-CCTCATCCCTCTCATGCTGTCTA-3′. The del(GJB6-D13S1830) and the del(GJB6-D13S1854) mutations in the GJB6 gene were tested by amplifying the breakpoint-containing fragments as described by del Castillo et al.14 The A1555G mutation was screened according to the protocol of Estivill et al.15

Linkage analysis

A genome-wide screening was performed with 382 microsatellite markers distributed with an average spacing of 10 cM (ABI Prism Linkage Mapping Set 2.5, Applied Biosystems, Foster City, CA, USA). Additional microsatellite markers (D17S805, D17S2196, D17S783, D17S1873, D17S2206 and D17S2207) within the DFNB3 chromosomal region were also amplified using fluorescent-labeled primers. All fluorescent-labeled PCR products were analyzed in the MegaBACE 1000 DNA Analysis System with the software Genetic Profiler version 2.2 (Amersham Biosciences).

MYO15A gene analysis

The exons of the MYO15A gene were sequenced using the DYEnamic ET Dye Terminator Cycle Sequencing Kit (Amersham Biosciences) and analyzed in the MegaBACE 1000 DNA Analysis System (Amersham Biosciences). The primers' sequences to amplify all exons of the MYO15A gene were suggested by Dr Thomas Friedman. On average, about 20 nt flanking coding sequences were examined. Nomenclature of the mutations was adapted to follow the recommendations of den Dunnen and Antonarakis.16 Accordingly, nucleotide 1 is the A of the ATG-translation initiation codon in GenBank accession number AF144094. For mutation description in the protein level, the GenBank accession number NP_05723 was used.

To characterize the frameshift mutation found in exon 62 (MYO15A gene) in samples from patients V:1, V:2, V:3, V:4 and VII:2 cloning of the PCR products was performed using pGEM-T Easy Vector Systems I (Promega) kit before sequencing.

Lod score calculations

Lod scores were calculated by using MLINK of the FASTLINK computer package.17 The disease was coded as fully penetrant while the disease allele frequency was set at 0.0001 in compliance with published studies. Meiotic recombination frequencies were considered to be equal for male and female subjects. Allele frequencies for the microsatellite markers were set to be 1/N, N being the number of different alleles found in the family.

Results and discussion

We studied 26 individuals affected by prelingual hearing loss belonging to the same consanguineous family that lived in a small remote rural village (Figure 1). From the 26 affected subjects, 24 were born from 12 consanguineous marriages. Consanguinity was not documented for the parents of the proband (VII:3) and for the parents of the subject VII:4. Out of the 12 consanguineous marriages, 11 shared a common ancestral couple (I:1 and I:2). However, consanguinity between the individuals IV:1 and IV:2 (branch 1 from Figure 1) could not be related to the couple I:1 and I:2, but was due to the common ancestors II:5 and II:6.

In most of the audiometric evaluated subjects (22 of 23), deafness was sensorineural, severe to profound with a prelingual onset (Figure 2a). One subject (VIII:1) had mixed moderate hearing impairment also with a prelingual onset (Figure 2b). No other abnormalities were observed in these 23 subjects. The remaining three affected individuals also had mental impairment, which prevented the conduction of the pure tone audiometry (VI:4, VI:17 and VI:19), therefore, we could not characterize their deafness.

Figure 2
figure 2

(a) Tonal audiometry showing the average thresholds of the 22 subjects with sensorineural severe to profound hearing impairment; (b) tonal audiometry of patient VIII:1 showing mixed hearing loss.

Based on the extensive consanguinity displayed by this family, we assumed that the pattern of inheritance was autosomal recessive and that a single deafness locus should be segregating in the pedigree, explaining all cases of deafness. Extended pedigrees with high number of consanguineous marriages are considered powerful tools to map new loci through homozygosity mapping because of the expected genetic homogeneity.

After ruling out frequent causes of genetic deafness, such as mutations in the GJB2 gene, the two deletions (delGJB6(D13S1830) and delGJB6(D13S1854)) involving the GJB6 gene and the A1555G mitochondrial mutation, a genome-wide scan was performed. However, the genome-wide scan results did not allow us to find a common region of linkage and/or region of homozygosity for all 26 deaf subjects. While accounting for the possibility of genetic heterogeneity within the pedigree, the most suggestive candidate region to explain deafness in the majority of the affected individuals appeared to be the DFNB3 locus (black and gray haplotypes in Figure 1). Segregation analysis of the haplotypes showed that 15 of the 26 affected subjects were homozygotes for the DFNB3 chromosomal region (black haplotypes displayed in branch 2 of Figure 1). This haplotype analysis also suggested that the four affected sibs (V:1, V:2, V:3 and V:4) from branch 1 (Figure 1), whose parental consanguinity was not related to the same ancestral couple from branches 2 and 4, were compound heterozygotes for mutations in the DFNB3 gene (black and gray haplotypes in Figure 1). Another deaf subject belonging to branch 2 (VII:2, * of Figure 1), also appeared to be a compound heterozygote for mutations in the DFNB3 gene. Furthermore, there was one subject who inherited only one of the risk haplotypes (V:17) and five subjects, including the proband, who did not inherit any of the risk haplotypes (VI:17, VI:19,VII:3, VII:4 and VIII:1).

Lod score calculations were performed excluding all five subjects with none of the risk haplotypes and omitting some of the inbreeding loops due to software limitations. The highest two-point lod scores, 12.1 for θ=0.01 and 10.81 for θ=0.01, were obtained with markers D17S805 (1 Mb apart from the MYO15A gene) and D17S2207 (D17S2207 being located inside the MYO15A gene, intron 1–2), respectively.

In the 15 subjects that were homozygous for a haplotype in the DFNB3 chromosomal region (branch 2 in Figure 2), we found a novel frameshift mutation c.10573delA in the last exon of the MYO15A gene (Figure 3a and b). This mutation would eliminate the last six amino acids at the C-terminus of myosin-XVa, which includes the four amino-acid long class 1 PDZ binding ligand, and would abolish the natural stop codon leading to the addition of 28 novel amino acids to the protein (p.Ser3525fs). In the five subjects whose haplotype analysis indicated two different mutations, we found another novel frameshift mutation c.9957_9960delTGAC in exon 62, in addition to the c.10573delA in exon 66 (Figure 3c and d). This mutation would lead to a premature stop codon in the second novel codon caused by the frameshift (p.Asp3320fs), thus it would eliminate 211 amino acids of the C-terminus of myosin XVA, which include approximately half of the second FERM domain and the entire C-terminal class 1 PDZ ligand. We concluded that those mutations were pathogenic and were the cause of deafness in the 20 out of the 26 deaf subjects ascertained from the pedigree (Table 1). Thus, we confirmed the hypothesis that patients from branch 1 were compound heterozygotes for mutations in the MYO15A gene. Although their parents were first cousins, their deafness was not related to the consanguinity but to two different MYO15A mutations. To try to find out the frequency of those mutations in a deaf Brazilian population, we screened both mutations in a cohort of 70 deaf probands ascertained in our Genetic Counseling Service whose family history indicated an autosomal recessive inheritance. But none was detected.

Figure 3
figure 3

Partial sequence of exon 66 of the MYO15A gene from (a) a control sample, (b) a sample bearing the c.10573delA mutation in homozygosis. Partial sequence of exon 62 of the MYO15A gene from patient (VII:2)'s (c) subcloned normal allele and (d) subcloned mutant allele bearing the c.9957_9960delTGAC mutation.

Table 1 Summary description of the genotypic data

The DFNB3 locus was first mapped to chromosome region 17p11.2 in a kindred from an isolated village called Bengkala in Bali, segregating autosomal recessive prelingual deafness.18 Subsequently, Wang et al19 found three different myosin-XV (MYO15A) mutations segregating with profound congenital deafness, one in the inbred Bengkala kindred and the others in two unrelated consanguineous families from India. In 2001, Liburd et al20 described three consanguineous families from Pakistan with homozygous missense MYO15A mutations causing deafness as well as one deaf Smith-Magenis's syndrome (del(17)p11.2) patient who was hemizygous for a missense mutation of MYO15A. Nal et al12 described 16 novel mutations in the MYO15A gene associated with deafness in families from Pakistan, India and Turkey. It is noteworthy that almost all families described with MYO15A mutations were consanguineous, one as large as the Brazilian (the Bengkala kindred) and 25 smaller ones, with only a single mutant allele as expected. The high number of exons of MYO15A, which discourage its mutational screening, might explain the few number of reports on MYO15A mutations. The MYO15A gene has 66 exons and its longest mRNA has 11,876 nt (AF144094). Myosin-XVa is a motor protein that uses energy from ATP hydrolysis to move along actin filaments. It is localized at the tips of hair cell stereocilia.21, 22, 23 As indicated by the study of Belyantseva et al,22 myosin-XVa might be the only motor in hair cells that selectively deliver cargo to the tips of stereocilia. Whirlin is a multi-PDZ domain-containing protein and its delivery by myosin-XVa to stereocilia tips is essential for stereocilia elongation and for the staircase architecture of the hair bundle. Both the c.10573delA and the c.9957_9960delTGAC novel mutations found in the Brazilian family lie in exons of MYO15A predicted to encode its tail domains and they probably eliminated the ability of myosin-XVa to bind and transport whirlin to the tips of stereocilia.22 Belyantseva et al22 showed that the C-terminal class 1 PDZ ligand of myosin-XVa interacts with the third PDZ domain of whirlin. Thus, elimination of either module would result in a failure of these two proteins to interact.

The subject V:17 (branch 2 of Figure 1), who presented sensorineural severe to profound deafness like his siblings, inherited only one of the risk haplotypes. Indeed, he carried only the c.10573delA allele as a single copy. Sequencing of the exons as well as exon–intron boundaries did not allow us to identify a second mutation. It is possible that a mutation in a regulatory element or in the promoter region of MYO15A is present in his other allele. Given the low social economic profile of the region and lack of health assistance, the hypothesis of environmental causes for deafness cannot be excluded completely. Besides, as the individual was born from a first-cousin marriage, the possibility of another recessive locus explaining his deafness could also be considered.

There are five remaining deaf subjects whose haplotypes did not indicate that MYO15A gene as the causative one. Among them, three (VI:17, VI:19 and VIII:1) were born from consanguineous marriages and exhibited distinct clinical presentations: two had also mental impairment (VI:17 and VI:19) and one had mixed hearing loss (VIII:1) (branch 4 in Figure 1). Patient VI:17 showed a severe mental retardation associated with hyperactivity. Patient VI:19 was described as presenting learning difficulties. There are about 150 entries in the OMIM database, which describe syndromes that may associate mental retardation and deafness, and all of them were characterized by other physical abnormalities or facial dysmorphisms. Physical examination revealed no additional abnormalities and it was not possible to associate their clinical presentation to any known syndrome. With the exception of embryopathies induced by rubella, toxoplasmosis or cytomegalovirus infection, which might result in polymalformations including hearing impairment, most forms of syndromic hearing impairment are of genetic origin.2 It is possible that the association of deafness and mental retardation was caused by environmental factors. Nevertheless, given the parental consanguinity, the most likely explanation for their deafness and/or mental retardation are homozygous mutant alleles of different loci segregating in this pedigree. The proband (VII:3) and the subject VII:4 (both from Branch 3 in Figure 1) presented a similar phenotype to those subjects bearing MYO15A mutations and no other clinical signs or symptoms. The proband and the subject VII:4 shared a similar DFNB3 haplotype, with exception of marker D17S2207. The hypothesis of a deletion of marker D17S2207 was ruled out based on the genotype of the proband's mother. Thus, the fact that VII:3 and VII:4 presented a similar DFNB3 haplotype is most likely a coincidence. Genetic causes as well as overlooked environmental causes could explain their conditions. Mutations in the coding region of the GJB2 gene were excluded in the five deaf patients without risk haplotypes and in patient V:17 with only one mutation detected. Moreover, in all microsatellites close to known autosomal recessive deafness loci, the six subjects exhibited different genotypes, indicating that genes in those known regions could not explain deafness in all of them.

The success of homozygosity mapping relies on the assumption that, for a rare recessive disease, patients in a consanguineous family will be homozygous for a mutation derived from a common ancestor of the parents. This strategy was successfully used many times in mapping genes responsible for deafness. Although, deafness is a frequent disease, there are many different loci associated. With exception of mutations in the GJB2, PDS and CDH23 genes, reported mutations in each locus are relatively rare. Locus and allelic heterogeneity within the same consanguineous pedigree, represents one of the important pitfalls in the homozygosity mapping strategy. Studying only closely related individuals is commonly pointed out to avoid the pitfall of genetic heterogeneity. The results found in the Brazilian pedigree represent a departure from both expectations and there are other examples in the literature. Van Soest et al24 described a genetic isolate population from the Netherlands in which two different loci responsible for autosomal recessive retinitis pigmentosa were segregating. De Brouwer et al25 studied a large family with many individuals affected by autosomal recessive nonsyndromic childhood hearing loss (DFNB). Failure to demonstrate linkage in a genome-wide scan has suggested genetic heterogeneity for the hearing loss in this family: patients in one branch of the family (branch C) were homozygous for the 35delG mutation in the GJB2 gene (DFNB1); patients from branch A were homozygous for a mutation in the CDH23 gene; patients in branch B were compound heterozygotes for the CDH23 gene mutation found in branch A and a second mutation. Fendri et al26 also described genetic heterogeneity within a consanguineous family involving two genes responsible for Sarcoglycanopathies (LGMD 2D and LGMD 2C). In 2000, Miano et al27 reported why their genome-wide linkage analysis failed to identify the chromosomal region associated with the enhanced S-cone syndrome in three consanguineous families. Later mutational analysis revealed homozygous mutations in two of the families, but in one family, three affected individuals were homozygous for a mutation and one was a compound heterozygote, with a yet unidentified mutation.

In summary, two different novel mutations in the MYO15A gene fully explain deafness in 20 out of 26 affected subjects in the Brazilian inbred pedigree (Table 1). In addition, it is possible that a further unrecognized MYO15A mutant allele is present in the subject with only one MYO15A mutation detected. The cause of the deafness in the remaining five subjects does not appear to be related to mutations in MYO15A and other unidentified loci may be involved, though environmental factors could not be fully excluded.

Finally, we conclude that at least two mutations in the MYO15A gene and other genetic and/or environmental factors caused deafness in this large consanguineous Brazilian pedigree.